# Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

> **NCT00137930** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 250 (—)

## Conditions studied

- Infections, Rotavirus

## Interventions

- **BIOLOGICAL:** Live attenuated rotavirus vaccine

## Key facts

- **NCT ID:** NCT00137930
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 250 (—)
- **Last updated:** 2016-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00137930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00137930, "Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00137930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*